Bartonella henselae is one of the most common zoonotic agents acquired from companion animals (cats) in industrialized countries. Nonetheless, although the prevalence of infections in cats is high, the number of human cases reported is relatively low. One hypothesis for this discrepancy is that B. henselae strains vary in their zoonotic potential. To test this hypothesis, we employed structured sampling to explore the population structure of B. henselae in the United Kingdom and to determine the distribution of strains associated with zoonotic disease within this structure. A total of 118 B. henselae strains were delineated into 12 sequence types (STs) using multilocus sequence typing. We observed that most (85%) of the zoonosis-associated strains belonged to only three genotypes, i.e., ST2, ST5, and ST8. Conversely, most (74%) of the feline isolates belonged to ST4, ST6, and ST7. The difference in host association of ST2, ST5, and ST8 (zoonosis associated) and ST6 (feline) was statistically significant (P < 0.05), indicating that a few, uncommon STs were responsible for the majority of symptomatic human infections.
Bartonella henselae infections, manifesting most frequently as cat scratch disease (9) , are one of the most common zoonoses acquired from companion animals in industrialized countries (15) (16) (17) . In the reservoir host, the domestic cat, the prevalence of B. henselae bacteremia can exceed 40% (8) , although it is usually somewhat lower in more temperate regions such as the United Kingdom, where the prevalence was found to be about 9% (6) . Although the isolation of B. henselae from the blood of infected cats is straightforward, obtaining isolates from humans is difficult, and hence almost all human cases are diagnosed using serological or PCR-based approaches (1, 10, 11, 15) .
Genetic diversity among B. henselae strains has been assessed using different genotypic methods (11, 25, 30) , and all have delineated multiple genotypes (2-5, 7, 10, 15, 18, 20, 21) . A study in the Netherlands, based on comparison of 16S rRNA gene sequences, provided the first evidence that B. henselae strains possessing a particular genotype were more frequently associated with zoonosis than others (5) . Further support for this observation has resulted from the use of multilocus sequence typing (MLST) (1, 15, 20) . The first application of MLST to B. henselae involved 37 feline and human isolates and identified seven sequence types (STs) that formed three deeprooted lineages, termed clonal complexes (CCs), within the species (15) . The study revealed that human isolates were significantly overrepresented in one particular ST, ST1 (15) . A subsequent survey of 182 B. henselae isolates acquired from archives around the world also found that ST1 was significantly associated with human infection and that, broadly, the geographical distribution of STs was not homogenous (1) . However, in both MLST studies, the sampling of strains was not coordinated either geographically or temporally. Furthermore, the number of human-associated B. henselae isolates examined was low.
We built on these earlier studies by (i) rigorously testing for the existence of temporal and national geographic determinants on the population structure of B. henselae, (ii) developing and employing a non-culture-based MLST protocol to facilitate genotyping of B. henselae strains infecting symptomatic humans and thus extending exploration of their diversity in relation to the natural (feline-infecting) B. henselae population, and (iii) introducing a online database for the storage and sharing of B. henselae MLST data.
MATERIALS AND METHODS
Collection of cat blood samples and recovery and identification of B. henselae isolates. Feline blood samples were provided by six veterinary hospitals and clinics (Table 1) , selected primarily on the basis of their geographic spread across England. Samples were not collected specifically for this project but rather were residual samples from cats undergoing other tests. Cats were included in the study if at least 0.5 ml of blood remained once all the required veterinary tests had been performed. Samples that shared clear epidemiological links, such as repeated collections from the same animal or samples from animals living at the same address, were excluded from the study.
Primary isolates were obtained by freezing samples at Ϫ20°C for 24 h and then plating onto Columbia agar plates (Oxoid, United Kingdom) containing 10% defibrinated horse blood and incubating the plates at 35°C in a 5% CO 2 atmosphere for 4 weeks. When putative colonies of bartonellae were observed, sweeps through them were subcultured onto fresh medium. DNA extracts were prepared by boiling suspensions of bacteria in sterile distilled water for 10 min. Bartonella DNA was detected using the second round of a seminested PCR assay targeting the Bartonella 16S-23S rRNA intergenic spacer region (ISR) (28) and characterized by sequencing of the PCR product in both directions using the primers used for amplification (28) .
Collection of clinical specimens from humans and detection of Bartonella DNA. The Health Protection Agency (HPA) offers a serology-based service for diagnosis of suspected Bartonella infections in humans. In November 2005 we instigated a follow-up study of all serology-positive patients. Sera were examined for the presence of B. henselae and Bartonella quintana antibodies using Bartonella IgG and IgM indirect immunofluorescent-antibody test kits (Focus Diagnostics, Cypress, CA). The manufacturer's criteria were adopted for the interpretation of serological results but with slight modification (13) . Thus, an IgM titer of Ͼ20 was considered evidence of current or recent infection, an IgG titer of Ն256 was considered presumptive evidence of recent infection, a single IgG titer of 128 was considered evidence of infection at an undetermined time, and stable or falling IgG titers from 128 in two sera taken more than 10 days apart was considered suggestive of past infection. For patients who fulfilled these criteria, demographic and clinical data were extracted from the specimen request forms and a report was sent to the requesting laboratory asking for clinical material suitable for PCR-based confirmatory diagnostics. DNA was extracted from clinical material using a QIAamp DNA minikit (Qiagen, Hilden, Germany) at the HPA Centre for Infections in London. Extracts were typically prepared in batches of between 1 and 3 samples. A water-only negative extraction control was concurrently prepared with each batch. Extracts and extraction controls were sent to the University of Liverpool for PCR analysis. The presence of DNA from Bartonella species was determined using the seminested version of the ISRtargeting PCR (28) and sequencing, as described above. A positive control, comprising Bartonella bacilliformis DNA, and a water-only negative control were concurrently tested with each batch of samples/extraction controls. Reaction mixes for the first and second stages of the assay were each prepared in dedicated laboratories, designed for purpose, in which no other activities took place and which were remote from laboratories where amplification products were prepared for sequencing.
MLST. Sequence data were obtained for the eight genetic loci described in the previously defined B. henselae MLST scheme (Table 2) (1, 15). For feline isolates, these data were obtained using previously described PCRs (15) . However, when DNA extracts prepared from B. henselae-infected human tissues were incorporated into these assays, they failed to yield discernible amplification products. To circumvent this problem, an approach using nested PCRs was developed. For each MLST locus, additional oligonucleotide primers targeting sequences close to, but outside, those targeted by the previously described primers were designed (Table 2 ). These new primers were used in first-round PCRs, and then products of these assays were incorporated as templates into second-round PCRs that employed the previously described primers. Each firstround reaction mixture contained 12.5 l 2ϫ PCR master mix (Abgene, Epsom, Surrey, United Kingdom), 0.5 l of a 20-pmol l Ϫ1 solution of both forward and reverse primers, 10.5 l water, and 1 l DNA extract. Reaction mixtures were exposed to a thermal program of 96°C for 5 min followed by 40 cycles of 96°C for 10 s, 55°C for 10 s, and 72°C for 50 s, with a final extension step at 72°C for 10 min. The second-round reaction mixture comprised 12.5 l 2ϫ PCR master mix, 0.5 l of a 20-pmol l Ϫ1 solution of both forward and reverse primers, 9.5 l water, and 2 l of the first-round reaction mix. The thermal program described above was used. MLST typing of human-associated B. henselae strains was performed on an ad hoc basis during the course of the study period, most often individually. To reduce the risk of cross-contamination, no positive controls were used for nested MLST PCRs; hence, only water-only negative controls were used. Reaction mixes for each stage of the MLST assays were prepared in dedicated laboratories, as detailed above for the ISR-targeting assay.
The nucleotide sequences of MLST amplification products were determined as described above and were analyzed and verified using Chromas Pro V1.4.1 (Technelysium Pty Ltd., Queensland, Australia). Alignment of verified sequences was carried out using MEGA V4.0 (27) . Alleles and STs were assigned in accordance with published data (1, 15, 20, 22, 29) . New allelic combinations were assigned to new STs in their order of detection. All MLST data generated during this study and from previous work (1, 15) , together with details of the provenance of the B. henselae strains from which these data were derived, were uploaded onto a newly created publicly available internet database hosted on the MLST website (http://bhenselae.mlst.net). The juxtapositions of STs within the B. henselae population structure were examined using eBURST (http://eburst .mlst.net) to analyze differences in allelic profiles (12, 26) and phylogeny inferred from alignments of concatenated sequences. Phylogenetic inferences were carried out using MEGA V4.0 (27) and included maximum-likelihood, parsimony, and neighbor-joining algorithms.
Statistical analysis. The existence of significant geographical or seasonal variation of STs was assessed using Pearson's chi-square test for association in STATA V10. Values were considered to be statistically significant if the P value was Յ0.05 (5%). The relative frequencies of the feline-and human-associated strains within each ST were compared with the overall frequency of isolates in this study using Fisher's exact test, with values considered to be statistically significant if the P value was Յ0.05 (5%).
RESULTS
Prevalence of Bartonella spp. in cats in the United Kingdom and MLST of feline isolates. Isolates were obtained from 103 of 1,782 feline blood samples (5.8%) ( Table 1) . B. henselae was cultured from 96 samples (5.4%) and Bartonella clarridgeiae from seven (0.4%). Complete MLST profiles were obtained for isolates recovered from 94 of the 96 samples. However, for isolates obtained from two samples, unequivocal sequence data could not be obtained. Thus, five single-colony picks were taken from cultures of these samples, and each pick was individually subjected to MLST. All picks yielded unequivocal sequence data, but different picks from the same cat yielded different STs, indicating coinfection; cat RSPCA210 was coinfected with ST5 and ST7, and cat BHAM76 was coinfected with ST6 and ST8. In total, 12 STs were encountered, three of which were new (designated ST27 to ST29 in order of detection). All the new STs were rare, and the B. henselae population was dominated by four STs, i.e., ST4, ST6, ST7, and ST8, which represented 19%, 41%, 15%, and 8% of isolates, respectively (Fig. 1) .
Geographical and temporal correlates for B. henselae STs. ST6 was the most common B. henselae ST found in English cats (Fig. 1) , being encountered at all six clinics involved in this study and during all seasons throughout the study period (see Fig. S1 and S2 in the supplemental material). Other common STs were also widely distributed, spatially and temporally (see Fig. S1 and S2 in the supplemental material). There was no statistical support for the geographical clustering of any STs ( 2 ϭ 13.8, P ϭ 0.54) or significant seasonal variation in the incidence of specific STs ( 2 ϭ 9.9, P ϭ 0.40).
To determine how the population structure of B. henselae in domestic cats (i.e., the natural reservoir) in England fits with that on a wider geographical scale, data from previous MLST studies (1, 15, 20, 22, 29) were collated and divided into three categories, i.e., United Kingdom, continental Europe, and the rest of the world (Table 3 ). The distributions of the common STs in these three categories were not random; ST1 and ST5 were significantly more common in countries outside Europe than in England, and ST5 and ST7 was significantly more common in continental Europe than in England. Conversely, ST4 and ST6 have been significantly more frequently isolated from English cats than from cats living elsewhere (Table 3) .
Identification and MLST analysis of zoonotic B. henselae strains. Appropriate clinical material (fresh, frozen lymph node biopsy specimens or aspirates, or heart valves) was received from 51 patients with serological evidence of Bartonella infection. Bartonella DNA was detected in tissues from 32 patients (63%). Sequencing of ISR amplification products revealed that 20 patients were infected with B. henselae (Table 4) and that the remaining 12 patients were infected with B. quintana. The nested MLST PCR protocol successfully amplified all MLST loci from the 20 patients with symptomatic B. henselae infections. ST8 was the most frequent ST encountered (eight patients) and ST2 was also common (six patients), while ST5 was found in three patients and ST1, ST4, and ST7 were each encountered in one patient ( Fig. 1; Table 4 ).
Relationship between ST and host species. Although ST6 was the most predominant ST among isolates recovered from cats in our study, it was not encountered among human-associated strains (P Ͻ 0.001). However, ST2 (P Ͻ 0.001), ST5 (P Ͻ 0.05), and ST8 (P Ͻ 0.001) were significantly more common among zoonotic strains than among feline isolates.
Analysis of B. henselae population structure. Phylogenetic analysis indicated that the 29 B. henselae STs encountered to date, including the three new STs reported in this study, formed well-supported, distinct clusters on three deep-rooted lineages (Fig. 1) . The existence of these clusters and lineages was supported by all three approaches to phylogenetic inference taken (data not shown). The proposed branching orders within each cluster were not robust, with low bootstrap support and inconsistency between algorithms. The three new STs were not specifically related to one another (Fig. 1) . Comparison of allelic profiles of STs using eBURST resulted in the three new STs being assigned to one of the three previously described CCs within the species (1, 15, 20, 22, 29 ) (see Fig. S3 in the supplemental material).
DISCUSSION
B. henselae is a successful parasite of domestic cats; surveys carried out worldwide have consistently demonstrated the presence of the organism in feline blood, almost always at a prevalence of greater than 5% and often exceeding 20% (8) . Cat ownership is common around the globe; for example, there are an estimated 8 million cats in the United Kingdom, living in 43% of the nation's households (23, 24) , and this popularity creates a common and widespread natural reservoir for B. henselae. However, given the scale, and hence the potential public health threat, of this reservoir, the reported incidence of B. henselae zoonoses is remarkably low (the HPA diagnoses only about 125 patients per year in the United Kingdom (14) . There are several possible explanations for this discrepancy; for example, transmission of B. henselae to humans may be an extremely inefficient process, or transmission itself may be efficient but the virulence of B. henselae may be such that symptomatic infections are rare. However, a further explanation may be that B. henselae strains vary in their ability to provoke disease. This explanation has support from previous studies in which certain genotypes were found to be overrepresented among human-associated strains (1, 15, 29) . However, in all these studies, the validity of the association observed was somewhat compromised by the opportunistic manner in which strains were collected. Furthermore, the paucity of human isolates resulted in few being included in these studies. We have aimed to circumvent both these shortfalls. First, we attempted to sample the diversity of B. henselae strains circulating in humans and domestic cats in a single country during the same time period. Second, rather than genotype human-associated B. henselae isolates, we applied MLST to extracts of clinical material containing B. henselae DNA. This strategy has previously been applied for the genotyping of human-associated B. henselae strains with multispacer typing (MST), which is an approach similar to MLST (19) , and has also been very recently used in conjunction with MLST itself (29) .
We observed rich genetic diversity among the B. henselae strains circulating in the United Kingdom, delineating 12 different STs in the 118 strains studied. This figure is akin to that reported recently in an MLST-based study of B. henselae diversity in Germany (22) . In that work, 39 feline isolates were characterized into 17 STs distributed in all three of the previously defined CCs of the species (22) . However, such diversity was not observed in a recent study in Japan, in which only three STs, all belonging to CC1, were detected in 55 isolates characterized (29) . These observations suggest that B. henselae diversity is more pronounced in some parts of the world than in others. Furthermore, the frequency with which certain STs were encountered in the United Kingdom appears to be different from that worldwide and in mainland Europe, adding weight to previous work in which a geographic correlation of B. henselae STs was first demonstrated and extending this by revealing significant variation on a regional (i.e., United Kingdom versus mainland Europe) as well as on a global scale. We also attempted to identify temporal variation in ST incidence but could find no evidence for this. We revealed a significant correlation between specific STs and human disease in the United Kingdom. We found that ST2, ST5, and ST8 were significantly associated with zoonosis. Although the finding of a correlation between a specific ST and human disease was in accordance with earlier work (1, 15) , previous studies found that human-associated strains were overrepresented in ST1, as opposed to ST2, ST5, and ST8. Why these three STs, and not ST1, present the greatest public health risk in the United Kingdom is unclear; however, given that geography is a determinant of B. henselae population structure, it is not an unsurprising observation. It is noteworthy that the vast majority of human-associated isolates included in earlier MLST studies were not from Western Europe (1, 15, 20, 22, 29) , and the worldwide zoonotic importance of ST1 was determined using univariant analysis without considering geographic influence. Thus, whereas B. henselae strains belonging to ST1 may be more likely to be associated with zoonosis in Australia, Japan, and maybe the United States, this association does not necessarily hold elsewhere, as demonstrated in our study. Further application of MLST on a national or regional scale will be necessary to resolve this.
The B. henselae population structure defined by MLST appears to be generally congruent with that defined using MST (18) , and using both approaches, MLST CC1/MST cluster 1 contains significantly more human-associated strains than other clusters (1, 15, 19) . However, a recent study using MST to characterize human-associated strains predominantly from France found that many belonged to MST cluster 3, which corresponds to MLST CC2 (19) . Furthermore, the distribution of the genotypes of human-associated strains was not significantly different from that of the genotypes of feline isolates. These observations are surprising given that they are discrepant with our work and previous MLST-based studies (1, 15) , and explaining the discrepancy is difficult. Perhaps MST geno- a Isolates are broken down into those from the United Kingdom, the rest of Europe, and the rest of the world (including Europe). The numbers of isolates assigned to each ST were calculated from previous MLST studies (1, 15, 20, 22, 29 Why specific STs are more frequently associated with symptomatic human infections than others is uncertain; clearly, the ability to infect humans holds no selective advantage for B. henselae, as humans are accidental hosts, and thus the zoonotic importance of these STs must be an unfortunate side effect of some other adaptation. Indeed, whether these STs share common determinants of zoonotic relevance or whether each possesses unique traits that coincidently result in more frequent human disease is unknown. Given this uncertainty, identifying the genetic basis of the specific zoonotic threat posed by these STs is likely to be extremely difficult. Nonetheless, the use of comparative genomics may, at least, offer a means to identify ST-specific genetic "motifs" and could help identify "virulence" factors associated only with those B. henselae STs which are most frequently associated with zoonosis.
